Peter Maccallum Cancer Centre, Australia
Clinical trials sponsored by Peter Maccallum Cancer Centre, Australia, explained in plain language.
-
New scan may spare men from unnecessary prostate biopsies
Diagnosis OngoingThis study looks at whether adding a PSMA PET scan can better detect significant prostate cancer in men whose MRI results are unclear or negative. About 660 men with no prior prostate cancer or biopsy will be randomly assigned to receive either standard care or an additional PSMA…
Phase: PHASE3 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Diagnosis
Last updated May 26, 2026 06:16 UTC
-
New registry to monitor PSMA therapy in prostate cancer patients
Knowledge-focused OngoingThis study is a registry that collects information on 500 men with metastatic castration-resistant prostate cancer who are treated with PSMA theranostics. The goal is to track how well the treatment lowers PSA levels and to monitor any side effects. The registry does not test a n…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated May 26, 2026 06:14 UTC
-
New Total-Body PET scanner could slash radiation for cancer patients
Knowledge-focused OngoingThis study tests a new total-body PET scanner that may produce clearer images with less radiation. About 25 adults with cancer will get scanned on both the new and standard machines. The goal is to see if the new scanner works just as well or better, potentially making scans safe…
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated May 26, 2026 06:14 UTC